Abstract: A dosage form is disclosed for delivering pentoxifylline to a patient in need of pentoxifylline therapy. A method is discussed for delivery pentoxifylline to a patient at a dosage form controlled rate over an extended period of time.
Type:
Grant
Filed:
May 24, 1995
Date of Patent:
February 18, 1997
Assignee:
ALZA Corporation
Inventors:
Patrick S. L. Wong, George V. Guittard, Atul D. Ayer
Abstract: A process is disclosed and claimed for preparing a therapeutic composition comprising asteroid or a dosage form comprising the composition, which therapeutic composition or dosage form is indicated for human administration.
Type:
Grant
Filed:
November 10, 1994
Date of Patent:
January 21, 1997
Assignee:
Alza Corporation
Inventors:
Jeri D. Wright, Brian L. Barclay, Linda E. Atkinson
Abstract: The invention disclosed comprises a method for administering the antidiabetic drug glipizide to a patient in need of glipizide in need of antidiabetic therapy.
Type:
Grant
Filed:
May 16, 1995
Date of Patent:
January 7, 1997
Assignee:
ALZA Corporation
Inventors:
Anthony L. Kuczynski, Atul D. Ayer, Patrick S.-L. Wong
Abstract: This invention resides in the field of bioerodible polymers for use as drug delivery vehicles. In particular, this invention addresses means for controlling the rate of biodegradation and degradation in general of such polymers.
Abstract: The present invention is directed to erodible delivery devices and to the compositions comprising the devices. The devices comprise (a) a body formed of a bioerodible polymer or polymers together with a required excipient not generally considered to be a pore-former ("required excipient"), and (b) an active agent. The agent is released from the device at a controlled rate and in a therapeutically effective amount, with the rate being primarily independent of the erosion rate of the polymer. The rate of release of the active agent from the polymeric compositions of the present invention is significantly increased over the rate of release dependent on erosion of the polymer matrix. The invention makes possible the increased control over and improved reproducibility of the release profile of the agent from the polymer.
Type:
Grant
Filed:
January 21, 1994
Date of Patent:
August 6, 1996
Assignee:
Alza Corporation
Inventors:
Wouter E. Roorda, Fred P. Ehnow, Estela Basso, Karly S. Wang, Sharon M. Fujita
Abstract: The present invention provides a gas generating engine for driving a beneficial agent dispensing device. The engine comprising (a) a solid composition comprising an acidic compound or a basic compound, or a combination thereof, and (b) a means for maintaining substantially constant the surface area of the solid composition exposed to a reservoir fluid comprising water, or water and an acidic compound, or water and a basic compound, wherein in operation, the solid composition is exposed to the reservoir fluid which dissolves the solid composition and causes it to generate a gas, the gas being a driving fluid to dispense a beneficial agent. The present invention further provides a fluid driven dispensing device for delivering an agent into an environment of use, the device be driven by the gas generating engine.
Type:
Grant
Filed:
January 31, 1994
Date of Patent:
July 30, 1996
Assignee:
ALZA Corporation
Inventors:
Stanley A. Mercado, Mark M. McPhee, Avtar S. Nat, Su I. Yum, Scott A. Bura
Abstract: Controlled-release particles containing biologically effective agents such as therapeutic drugs and local anesthetics are suspended in a liquid suspending vehicle which has an elevated viscosity, the viscosity being substantially higher than that of water. Preferred vehicles are non-aqueous liquids and aqueous media which contain a dissolved polymer to increase the viscosity of the vehicle. Regardless of the composition of the media, however, the increased viscosity permits the use of particles of a relatively large size without a loss of suspension stability or localized application. The large particles offer the advantage of a longer release profile, and thus more prolonged activity of the agent.